1. Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough. Issue 3 (2nd August 2021) Authors: Ludbrook, Valerie J.; Hanrott, Kate E.; Kreindler, James L.; Marks-Konczalik, Joanna E.; Bird, Nick P.; Hewens, Debbie A.; Beerahee, Misba; Behm, David J.; Morice, Alyn; McGarvey, Lorcan; Parker, Sean M.; Birring, Surinder S.; Smith, Jaclyn Journal: ERJ open research Issue: Volume 7:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome. (April 2023) Authors: Begg, Malcolm; Amour, Augustin; Jarvis, Emily; Tang, Teresa; Franco, Sara Santos; Want, Andrew; Beerahee, Misba; Fernando, Disala; Karkera, Yakshitha; Sander, Clare; Southworth, Thomas; Singh, Dave; Clark, Jonathan; Nejentsev, Sergey; Okkenhaug, Klaus; Condliffe, Alison; Chandra, Anita; Cahn, Ant... Journal: Pulmonary pharmacology & therapeutics Issue: Volume 79(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Does short‐term placebo response predict the long‐term observation? Meta‐analysis on forced expiratory volume in 1 second from asthma trials. (13th May 2014) Authors: Yang, Shuying; Gomeni, Roberto; Beerahee, Misba Journal: Journal of clinical pharmacology Issue: Volume 54:Number 11(2014:Nov.) Page Start: 1207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose response of umeclidinium administered once or twice daily in patients with COPD: A pooled analysis of two randomized, double‐blind, placebo‐controlled studies. (24th June 2014) Authors: Donohue, James F.; Kalberg, Christopher; Shah, Palvi; Beerahee, Misba; Mehta, Rashmi; Gunawan, Rudy; Church, Alison Journal: Journal of clinical pharmacology Issue: Volume 54:Number 11(2014:Nov.) Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inhibition of capsaicin‐driven nasal hyper‐reactivity by SB‐705498, a TRPV1 antagonist. (May 2014) Authors: Holland, Carlijn; van, Cornelis; Denyer, Jane; Smart, Kevin; Segboer, Christine; Terreehorst, Ingrid; Newlands, Amy; Beerahee, Misba; Fokkens, Wytske; Tsitoura, Daphne C. Journal: British journal of clinical pharmacology Issue: Volume 77:Number 5(2014:May) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge. (October 2020) Authors: Mole, Sarah; Harry, Anya; Fowler, Andy; Hotee, Sarah; Warburton, Joseph; Waite, Sarah; Beerahee, Misba; Behm, David J.; Badorrek, Philipp; Müller, Meike; Faulenbach, Cornelia; Lazaar, Aili L.; Hohlfeld, Jens M. Journal: Pulmonary pharmacology & therapeutics Issue: Volume 64(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Longitudinal Model‐Based Meta‐Analysis of Lung Function Response to Support Phase III Study Design in Chinese Patients With Asthma. Issue 6 (7th April 2022) Authors: Yang, Shuying; Simeoni, Monica; Beerahee, Misba Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 6(2022) Page Start: 1286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pediatric Population Pharmacokinetic Modeling and Exposure–Response Analysis of Ambrisentan in Pulmonary Arterial Hypertension and Comparison With Adult Data. (29th January 2023) Authors: Okour, Malek; Thapar, Mita M.; Farrell, Colm; Lukas, Mary Ann; Beghetti, Maurice; Beerahee, Misba Journal: Journal of clinical pharmacology Issue: Volume 63:Number 5(2023) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD. (15th May 2018) Authors: Mehta, Rashmi; Pefani, Eleni; Beerahee, Misba; Brealey, Noushin; Barnacle, Helen; Birk, Ruby; Zhu, Chang‐Qing; Lipson, David A. Journal: Journal of clinical pharmacology Issue: Volume 58:Number 11(2018) Page Start: 1461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial. Issue 3 (25th October 2022) Authors: Mohan, Divya; Rossiter, Harry; Watz, Henrik; Fogarty, Charles; Evans, Rachael A; Man, William; Tabberer, Maggie; Beerahee, Misba; Kumar, Subramanya; Millns, Helen; Thomas, Sebin; Tal-Singer, Ruth; Russell, Alan J; Holland, Marie Claire; Akinseye, Chika; Neil, David; Polkey, Michael I Journal: Thorax Issue: Volume 78:Issue 3(2023) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗